NCT06119243

Brief Summary

Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Mar 2023

Typical duration for all trials

Geographic Reach
2 countries

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Mar 2023Dec 2026

Study Start

First participant enrolled

March 21, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 12, 2024

Status Verified

December 1, 2024

Enrollment Period

3.3 years

First QC Date

October 30, 2023

Last Update Submit

December 8, 2024

Conditions

Keywords

MyopiaMyopia controlProgressive myopiaNear vision behaviorOutdoor activityEnvironmentLight exposure

Outcome Measures

Primary Outcomes (3)

  • Near viewing duration

    Duration during near tasks

    12 months

  • Near viewing distance

    Distance during near tasks

    12 months

  • Outdoor time

    Ambient illumination to determine time spent outdoors

    12 months

Secondary Outcomes (3)

  • Objective cycloplegic central refraction

    12 months

  • Axial length

    12 months

  • Subjective cycloplegic central refraction

    12 months

Interventions

ViviorDEVICE

The Vivior is a wearable clip-on sensor that objectively quantifies near viewing distance and duration, and ambient illumination. The Vivior will be attached to the spectacles frame of children undergoing myopia control treatment.

Eligibility Criteria

Age4 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Myopic children will be recruited from the university based myopia control clinic. Some clinical sites have collaborated with community optometry practices so support recruitment.

You may qualify if:

  • Aged 6 to below 14 years old
  • Spherical equivalent myopic refractive error greater than -0.50 D
  • Best corrected logMAR visual acuity of 0.1 or better in each eye for 6- to 14-year-old children, and 0.2 logMAR or better than in each eye for 4 and 5-year-old children (adjusted for age-related expectations)
  • Good ocular and general health that would not preclude them from myopia control
  • Competent enough in English to fully understand the participant information and consent form
  • Willing to undergo treatment to slow myopia progression for one year

You may not qualify if:

  • Strabismus at distance or near, or amblyopia
  • Systemic or ocular conditions that may affect contact lens use (e.g. severe allergy) or refractive development (e.g. ptosis)
  • Previous history of ocular surgery, trauma or chronic ocular disease that may affect their vision
  • Ocular or systemic medication use which may interfere or interact with myopia treatment or ocular development
  • Child, parents or guardians not willing to comply with treatment and/or follow-up schedule and planning to migrate or move during the one-year study duration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

School of Optometry, University of California, Berkeley

Berkeley, California, 94720, United States

ACTIVE NOT RECRUITING

New England College of Optometry

Boston, Massachusetts, 02115, United States

RECRUITING

State University of New York (SUNY), College of Optometry

New York, New York, 10036, United States

NOT YET RECRUITING

School of Optometry and Vision Science, UNSW

Sydney, New South Wales, 2052, Australia

RECRUITING

Optometry and Vision Science, Queensland University of Technology

Kelvin Grove, Queensland, 4059, Australia

RECRUITING

MeSH Terms

Conditions

MyopiaMyopia, Degenerative

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Central Study Contacts

Pauline Kang, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer

Study Record Dates

First Submitted

October 30, 2023

First Posted

November 7, 2023

Study Start

March 21, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 12, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations